Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-9378
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab ; volume:16 ; number:1 ; day:2 ; month:6 ; year:2021 ; pages:1-6 ; date:12.2021
Infectious agents and cancer ; 16, Heft 1 (2.6.2021), 1-6, 12.2021
- Creator
-
Marcacci, Gianpaolo
Fiorentino, Giuseppe
Volzone, Francesco
Falcone, Umberto
Parrella, Roberto
Donnarumma, Daniela
D’Ovidio, Silvia
Annunziata, Anna
Micallo, Giovanni
Portella, Giuseppe
Chiara, Annarosaria De
Filippi, Rosaria De
Crisci, Stefania
Pinto, Antonio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13027-021-00376-1
- URN
-
urn:nbn:de:101:1-2021092619305042063330
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Marcacci, Gianpaolo
- Fiorentino, Giuseppe
- Volzone, Francesco
- Falcone, Umberto
- Parrella, Roberto
- Donnarumma, Daniela
- D’Ovidio, Silvia
- Annunziata, Anna
- Micallo, Giovanni
- Portella, Giuseppe
- Chiara, Annarosaria De
- Filippi, Rosaria De
- Crisci, Stefania
- Pinto, Antonio
- SpringerLink (Online service)
Other Objects (12)
Gastrointestinal Perforation after Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
Smoldering mantle cell lymphoma
Gastrointestinal Symptom-Free Multiple Lymphomatous Polyposis: An Atypical Case Presentation of Mantle Cell Lymphoma
Mantle Cell Lymphoma Case Report
Atypical burkitt's lymphoma transforming from follicular lymphoma
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis
An evaluation of the potential for drug–drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma
Mantle cell lymphoma with features of marginal-zone lymphoma
Emerging therapies in mantle cell lymphoma
Mantle cell lymphoma of the colon
A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma
Rituximab induced hypoglycemia in non-Hodgkin's lymphoma
Gastrointestinal Perforation after Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
Smoldering mantle cell lymphoma
Gastrointestinal Symptom-Free Multiple Lymphomatous Polyposis: An Atypical Case Presentation of Mantle Cell Lymphoma
Mantle Cell Lymphoma Case Report
Atypical burkitt's lymphoma transforming from follicular lymphoma
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis
An evaluation of the potential for drug–drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma
Mantle cell lymphoma with features of marginal-zone lymphoma
Emerging therapies in mantle cell lymphoma
Mantle cell lymphoma of the colon
A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma
Rituximab induced hypoglycemia in non-Hodgkin's lymphoma
Gastrointestinal Perforation after Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
Smoldering mantle cell lymphoma
Gastrointestinal Symptom-Free Multiple Lymphomatous Polyposis: An Atypical Case Presentation of Mantle Cell Lymphoma
Mantle Cell Lymphoma Case Report
Atypical burkitt's lymphoma transforming from follicular lymphoma
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis
An evaluation of the potential for drug–drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma
Mantle cell lymphoma with features of marginal-zone lymphoma
Emerging therapies in mantle cell lymphoma
Mantle cell lymphoma of the colon
A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma